A. Clarkson

发表

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

A. Gill, L. Delbridge, B. Robinson, 2003, The Journal of clinical endocrinology and metabolism.

Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas

A. Gill, L. Delbridge, B. Robinson, 2003 .

The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.

A. Chou, A. Gill, B. Skogseid, 2009, The Journal of clinical endocrinology and metabolism.

Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas

T. Dwight, A. Chou, C. Toon, 2014, The American journal of surgical pathology.

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

A. Chou, A. Gill, S. Sidhu, 2020, The American journal of surgical pathology.

Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.

A. Gill, K. McDonald, B. Robinson, 2009, The Journal of clinical endocrinology and metabolism.

The epithelioid BAP1‐negative and p16‐positive phenotype predicts prolonged survival in pleural mesothelioma

A. Chou, C. Toon, A. Gill, 2018, Histopathology.

Switch/sucrose‐non‐fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)‐deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas

A. Chou, A. Gill, M. Ahadi, 2021, Histopathology.

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma

C. Toon, A. Gill, J. Andrici, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer

C. Toon, A. Gill, J. Andrici, 2016, Modern Pathology.

Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.

A. Gill, E. Duncan, P. Ebeling, 2013, The Journal of clinical endocrinology and metabolism.

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma

S. O'toole, A. Chou, C. Toon, 2015, The American journal of surgical pathology.

Utilization of a MAB for BRAFV 600 E detection in papillary thyroid carcinoma

D. Capper, A. Deimling, A. Chou, 2012 .

Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

A. von Deimling, D. Capper, A. Chou, 2012, Endocrine-related cancer.

Utilization of a MAB for BRAF detection in papillary thyroid carcinoma

D. Capper, A. Deimling, C. Toon, 2012 .

Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.

B. Teh, A. Gill, D. Marsh, 2009, The Journal of clinical endocrinology and metabolism.

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma

S. O'toole, A. Gill, L. Horvath, 2013, Journal of Clinical Pathology.

ALK and ROS1 Overexpression is Very Rare in Colorectal Adenocarcinoma

A. Chou, C. Toon, A. Gill, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases

C. Toon, A. Gill, M. Schnitzler, 2015, Annals of Surgical Oncology.

BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas.

C. Toon, A. Gill, A. Clarkson, 2014, Pathology.

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma

A. Gill, R. Eckstein, A. Clarkson, 2010, Pathology.

Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population.

A. Chou, C. Toon, A. Gill, 2011, Human pathology.

Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias

A. Gill, D. Marsh, H. Dralle, 2006, The American journal of surgical pathology.

Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia

Amy Y. M. Au, R. Scolyer, A. Gill, 2003 .

Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).

A. Gill, D. Ranchère‐Vince, A. Decouvelaere, 2013, Human pathology.

Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity

J. McKenney, P. Tan, C. Magi-Galluzzi, 2014, The American journal of surgical pathology.

University of Birmingham Succinate dehydrogenase (SDH)-deficient renal carcinoma

J. McKenney, P. Tan, C. Magi-Galluzzi, 2014 .

NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases

A. Chou, A. Gill, C. Corless, 2019, Modern Pathology.

Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.

S. Fox, R. Scott, A. Gill, 2017, Pathology.

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

A. Chou, A. Gill, A. Richardson, 2010, Human pathology.

DNA damage‐inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression

A. Vargas, A. Chou, A. Gill, 2021, Histopathology.

Benign mesothelial cells as confounders when cytokeratin immunohistochemistry is used in sentinel lymph nodes.

A. Gill, A. Colebatch, A. Clarkson, 2011, Human Pathology.

PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours

A. Gill, A. Clarkson, L. Sioson, 2021, Endocrine Pathology.

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures

A. Gill, J. Timms, S. Pereira, 2011, British Journal of Cancer.

Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.

A. Gill, N. Pachter, I. Winship, 2011, The New England journal of medicine.

Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology

A. Chou, A. Gill, N. Pachter, 2011, The American journal of surgical pathology.

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma

T. Dwight, A. Chou, A. Gill, 2022, The American journal of surgical pathology.

Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients

H. Samaratunga, A. Vargas, H. Moch, 2021, Modern Pathology.

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma

W. Weichert, P. Schirmacher, A. Stenzinger, 2016, Medicine.

Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.

A. Chou, C. Toon, A. Gill, 2014, Human pathology.

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing

T. Dwight, A. Gill, D. Marsh, 2016, Scientific Reports.

Elevated serum FGF23 concentrations in plasma cell dyscrasias.

A. Gill, R. Mason, B. Robinson, 2006, Bone.

CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.

B. Teh, A. Gill, D. Marsh, 2010, Endocrine-related cancer.

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.

A. Gill, K. McDonald, S. Sidhu, 2009, Endocrine-related cancer.

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology

C. Toon, A. Gill, J. Andrici, 2015, Modern Pathology.

Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings

T. Dwight, K. Tucker, C. Toon, 2016, The American journal of surgical pathology.

Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.

C. Toon, A. Gill, J. Andrici, 2016, Pathology.

Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized

A. Chou, A. Gill, J. Andrici, 2017, The American journal of surgical pathology.

The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.

N. Traficante, S. Fereday, A. deFazio, 2016, Human molecular genetics.

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features

A. Chou, C. Toon, A. Gill, 2018, The American journal of surgical pathology.

Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.

A. Gill, K. McDonald, B. Robinson, 2008, Endocrinology.

When used together SS18–SSX fusion‐specific and SSX C‐terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases

A. Vargas, A. Chou, A. Gill, 2020, Histopathology.

High Expression of Plasminogen Activator Inhibitor-2 (PAI-2) is a Predictor of Improved Survival in Patients with Pancreatic Adenocarcinoma

C. Scarlett, A. Gill, T. Hugh, 2007, World Journal of Surgery.

EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer

N. Pavlakis, S. O'toole, A. Chou, 2014, Pathology.

BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer

A. Chou, C. Toon, A. Gill, 2013, Modern Pathology.

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.

M. Pajic, A. Chou, J. Samra, 2018, Human pathology.

BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome

Aung Ko Win, J. Hopper, A. von Deimling, 2013, The American journal of surgical pathology.

Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types

A. Chou, J. Samra, A. Gill, 2010, The American journal of surgical pathology.

Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors

L. Lipton, T. Dwight, A. Gill, 2013, The American journal of surgical pathology.

Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.

A. Gill, R. Clifton-Bligh, M. Elston, 2015, Human pathology.

Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression

A. Chou, J. Samra, A. Gill, 2012, Modern Pathology.

Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.

C. Toon, A. Gill, J. Andrici, 2016, Human pathology.

Loss of expression of BAP1 predicts longer survival in mesothelioma

C. Toon, A. Gill, J. Andrici, 2015, Pathology.

A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma

C. Toon, A. Gill, M. Schnitzler, 2014, PloS one.

NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2

A. Gill, J. Andrici, M. Bullock, 2017, The American journal of surgical pathology.

Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors

A. Gill, A. Clarkson, L. Sioson, 2020, Endocrine Pathology.

Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.

A. Gill, J. Andrici, M. Ahadi, 2016, Human pathology.

Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

H. Wheeler, K. McDonald, B. Robinson, 2008, Journal of Neuro-Oncology.

Real world experience of BRAFV600E mutation specific immunohistochemistry in colorectal carcinoma.

A. Gill, M. Bullock, P. Shepherd, 2018, Pathology.

Assessment of HER-2 Status in Pancreatic Adenocarcinoma: Correlation of Immunohistochemistry, Quantitative Real-Time RT-PCR, and FISH With Aneuploidy and Survival

C. Scarlett, A. Gill, A. Morey, 2005, The American journal of surgical pathology.

The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination.

A. Gill, D. Marsh, M. A. Hahn, 2012, Human molecular genetics.

The tumor suppressor CDC 73 interacts with the ring finger proteins RNF 20 and RNF 40 and is required for the maintenance of histone 2 B monoubiquitination

A. Gill, D. Marsh, M. A. Hahn, 2012 .

Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas.

A. Gill, A. Clarkson, L. Sioson, 2018, Pathology.

The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation

A. Gill, S. Sidhu, L. Delbridge, 2023, Endocrine Pathology.

Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.

C. Toon, A. Gill, J. Andrici, 2016, Human pathology.

Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer

S. O'toole, A. Chou, C. Toon, 2014, Pathology.

Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma

Tamara Sztynda, Anthony J Gill, J. Samra, 2016, PloS one.

Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer

A. Chou, C. Toon, A. Gill, 2014, PloS one.

Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.

J. Samra, A. Gill, J. Andrici, 2016, Journal of the American College of Surgeons.

Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.

C. Toon, A. Gill, J. Andrici, 2016, Pathology.

Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

A. von Deimling, D. Capper, A. Chou, 2012, Endocrine-related cancer.

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

A. Chou, A. Gill, A. Richardson, 2010, Human pathology.

Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.

C. Toon, A. Gill, J. Andrici, 2016, Pathology.

ALK and ROS1 Overexpression is Very Rare in Colorectal Adenocarcinoma

A. Chou, C. Toon, A. Gill, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.

B. Teh, A. Gill, D. Marsh, 2010, Endocrine-related cancer.